A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥ 18 Years of Age to <50 Years of Age Adults General population Monkeypox virus Monkeypox virus infection Pharmacological intervention Vaccination mRNA-1769